IVIVA Medical Company

IVIVA Medical was founded with the goal of developing autologous tissue constructs as a solution to end-state renal disease (ESRD). At IVIVA we’re developing therapies using proprietary printed biologic scaffolds to replicate physiologically functional tissue constructs; platforms with the potential to replicate autologous renal function. Our composite hydrogel scaffolds are created using computer designed architecture and provide a unique starting point for developing many types of perfusable tissue constructs. Along with our tissue engineering platforms we have developed a variety of biomimetic systems capable of modeling whole organ function in a range of tissue types

Investors

Industry: BioEngineering
Headquarters: Beverly, Massachusetts, United States
Founded Date: 2013
Employees Number: 11-50
Investors Number: 2
Total Funding: n/a
Estimated Revenue: Less than $1M
Last Funding Date: 2021
Last Funding Type: Seed

Visit Website
info@ivivamedical.com
Register and Claim Ownership